Weekly Clinical Updates

As infectious diseases such as SARS, Monkeypox, Polio, HIV, and Ebola travel the globe and garner media attention, Parasites Without Borders staff are curating resources in a timely, ongoing basis. We believe the information posted here is worthy of further examination by the science and medical communities. Our primary goal remains to bring the latest medical and biological information to the forefront for researchers and practicing physicians.

FIMRC Fundraiser x Parasites Without Borders Kicks Off This Spring

Throughout May, June, and July, donations made to Parasites Without Borders (PWB) will be matched by the organization and donated to Foundation for International Medical Relief of Children (FIMRC), for a total gift of up to $10,000. Founded in 2002 by Dr. Vikram D. Bakhru, FIMRC is a U.S.-based nonprofit organization that works to improve access to care through innovative, self-sustaining health programs. FIMRC works alongside communities to improve health from the ground up — including building necessary infrastructure, such as constructing or updating buildings; ensuring communities have access to a healthcare professional; and educating on preventive health.
Learn more at
fimrc.org

MicrobeTV Podcast

MicrobeTV is an independent podcast network for people who are interested in the life sciences. Our shows are about viruses, bacteria, parasites, evolution, immunology, and neuroscience.

Covid Oximeter

March 21, 2024

Lower vs Higher Oxygenation Target and Days Alive Without Life Support in COVID-19: The HOT-COVID Randomized Clinical Trial | Prevalence of Orthostatic Intolerance in Long COVID Clinic Patients and Healthy Volunteers: A Multicenter Study | Autonomic Cardiac Function in Children and Adolescents with Long COVID: A Case-controlled Study | Iron Dysregulation and Inflammatory Stress Erythropoiesis Associates with Long-term Outcome of COVID-19
Comparative study findings

March 14, 2024

Vaccine Effectiveness Against Long COVID in Children | Impact of Vaccination on the Association of COVID-19 with Cardiovascular Diseases: An OpenSAFELY Cohort Study | The Impacts of Nirmatrelvir–Ritonavir on Myocardial Injury and Long-Term Cardiovascular Outcomes in Hospitalized Patients with COVID-19 amid the Omicron Wave of the Pandemic
COVID: Active Vaccination/Immunity

March 7, 2024

Interim Effectiveness of Updated 2023–2024 COVID-19 Vaccines Against COVID-19 | Combined Protection of Vaccination and Nirmatrelvir-ritonavir in Adults | Ivermectin for COVID-19 in Adults in the Community (PRINCIPLE): An Open, Randomised, Controlled, Adaptive Platform | Cognition and Memory after COVID-19 in a Large Community Sample | Prospective Memory Assessment Before and After Covid-19 | What is the Impact of Long-term COVID-19 on Workers
Compilation of studies

February 29, 2024

Effectiveness of Nirmatrelvir-ritonavir on Severe Outcomes of COVID-19 in the Era of Vaccination | Randomized Controlled Trial of Molnupiravir SARS-CoV-2 Viral and Antibody Response | Spontaneous, Persistent, T cell–dependent IFN-γ Release in Patients | Blood–brain Barrier Disruption and Sustained Systemic Inflammation in Individuals | Prevalence of Persistent SARS-CoV-2 in a Large Community Surveillance Study | Long Term Outcomes of Hyperbaric Oxygen Therapy in Post Covid Condition
Graph comparing

February 22, 2024

Self-administered versus Clinician-performed BinaxNOW COVID Rapid Test: A Comparison of Accuracy | The Impact of COVID-19 Vaccination Prior to SARS-CoV-2 Infection on Prevalence of Long COVID among a Population-based Probability Sample of Michiganders, 2020-2022 | Estimates of Incidence and Predictors of Fatiguing Illness after SARS-CoV-2 Infection | Long-term risks of Respiratory Diseases in Patients Infected with SARS-CoV-2
Research findings on RSV and flu vaccines

February 15, 2024

Early Estimates of Nirsevimab Immunoprophylaxis Effectiveness against Hospital Admission | Redirecting Antibody Responses from Egg-adapted Epitopes Following Repeat Vaccination | Risk of Cardiovascular Events after Influenza | Risk of Death Following Chikungunya Virus Disease | Comparative Effectiveness of Alternative Intervals Between First and Second Doses | Early Mortality After the First Dose of Coronavirus Disease

Situation Dashboards

World_Health_Organization_logo_logotype

World Health Organization (WHO)

Novel Coronavirus (COVID-19) Situation from World Health Organization (WHO)
university-logo-small-horizontal-blue-no-clear-space-51c7fb4524

Johns Hopkins University (JHU)

Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering (CSSE) at JHU
1point3acres

COVID-19 in US and Canada

1Point3Acres Real-Time Coronavirus (COVID-19) Updates in US and Canada with Credible Sources
image

Genomic Epidemiology COVID-19

Genomic Epidemiology of (COVID-19) Maintained by the Nextstrain team, enabled by data from GISAID.

Sources for COVID-19 Information

World_Health_Organization_logo_logotype

World Health Organization (WHO)

U.S. Centers for Disease Control and Prevention

Centers for Disease Control, US

International Society for Infectious Diseases

International Society for Infectious Diseases

twiv-logo

This Week in Virology (TWIV)

Row triangle Shape Decorative svg added to bottom

Learn more about parasitic diseases and receive updates about Parasites Without Borders' initiatives and developments by subscribing to our newsletter.

Parasites Without Borders

Un recurso educativo integral sobre todos los aspectos de las enfermedades parasitarias y su impacto en la humanidad en todo el mundo.

Donate to Parasites Without Borders Today!

Ayude a llevar la información médica y biológica más reciente sobre enfermedades causadas por parásitos eucariotas a todos los médicos y estudiantes de medicina en los Estados Unidos.

Scroll al inicio